Reuters: Nepal’s miracle gel saves newborns from infection
“… ‘Navi Malam,’ or chlorhexidine, [is a gel] applied to avoid umbilical cord infection — a main cause of newborn deaths in the impoverished Himalayan nation [of Nepal]. Made by local firm Lomus Pharmaceuticals and backed by the government, [USAID], and other donors, the gel was introduced in 2011 in hospitals across Nepal and has helped to reduce the number of babies dying from umbilical cord infection…” (Sharma, 3/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.